A carregar...
Angiotensin Receptor Blocker Therapy for Heart Failure Patients: Is Combination Treatment a Feasible Prospect?
BACKGROUND: The addition of the angiotensin II type 1 receptor blocker (ARB) candesartan to a angiotensin‐converting enzyme inhibitor (ACEI) has been associated with improved clinical outcomes in patients with heart failure. However many do not tolerate combination therapy and concerns have been rai...
Na minha lista:
| Publicado no: | Clin Cardiol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley Periodicals, Inc.
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6653160/ https://ncbi.nlm.nih.gov/pubmed/19743497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.20635 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|